Hält derzeit Positionen bei Pharming Group NV, Veeva Systems Inc, Alpine Immune Sciences Inc and Ipsen SA
Position | Company | Period |
---|---|---|
Chairman of the Board of Supervisory Directors | Pharming Group NV | 25. Mai 2016 - |
Independent Director | Veeva Systems Inc | 7. Juli 2014 - |
Independent Director | Alpine Immune Sciences Inc | 25. Februar 2016 - |
Independent Director | Ipsen SA | 30. Mai 2018 - |
Director | Enumeral Biomedical Holdings Inc | 16. Dezember 2014 - 1. September 2017 |
Member of the Board of Supervisory Directors | Pharming Group NV | 30. April 2015 - 25. Mai 2016 |
Group Executive Vice President, Global Business Development and Chief Strategy Officer | Teva Pharmaceutical Industries Ltd | 1. Juni 2013 - 1. Januar 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-09-12 | 2023-09-11 |
Veeva Systems Inc
(VEEV)
|
GV Geplanter Verkauf |
2.500
-14.7%
224,85562.125 USD |
2.500 -14.7% | 224,85 | 562.125 USD | |
2023-03-06 | 2023-03-03 |
Veeva Systems Inc
(VEEV)
|
GV Geplanter Verkauf |
118
-0.7%
183,5121.654 USD |
118 -0.7% | 183,51 | 21.654 USD | |
2023-03-06 | 2023-03-03 |
Veeva Systems Inc
(VEEV)
|
GV Geplanter Verkauf |
2.540
-13.3%
181,85461.904 USD |
2.540 -13.3% | 181,85 | 461.904 USD | |
2022-04-01 | 2022-03-31 |
Veeva Systems Inc
(VEEV)
|
V Verkauf |
11.000
-37.1%
214,022.354.254 USD |
11.000 -37.1% | 214,02 | 2.354.254 USD | |
2020-03-05 | 2020-03-03 |
Ipsen SA
(IPN)
|
K Kauf |
300
63,8019.140 EUR |
300 | 63,80 | 19.140 EUR | |
2020-03-05 | 2020-03-02 |
Ipsen SA
(IPN)
|
K Kauf |
100
64,006.400 USD |
100 | 64,00 | 6.400 USD | |
2018-11-22 | 2018-11-19 |
Ipsen SA
(IPN)
|
K Kauf |
100
13.993,611.399.361 USD |
100 | 13.993,61 | 1.399.361 USD |